About
Mr. Turner has 25 years of experience as an entrepreneur, operating manager and venture capitalist. He founded Montreux and has been a General Partner/Managing Member since 1993. Immediately prior to founding Montreux, Mr. Turner was a Principal in the Turnaround Group for Berkeley International. Previously, he was the founding Chief Financial Officer of Oclassen Pharmaceuticals, a specialty pharmaceutical company focused in dermatology, which merged with Watson Pharmaceuticals (NYSE: WPI) in 1997. Mr. Turner started his career with Price Waterhouse in the high technology group. He holds a BS from California State University, Sacramento and attended the MBA program at the Haas School of Business at the University of California, Berkeley, where he has established the Turner Fellowship. Mr. Turner is a Certified Public Accountant. Mr. Turner is a member of the board of directors of GC Aesthetics, Moksha, OREXIGEN (NASDAQ: OREX), Renal CarePartners, and Tobira Therapeutics. Mr. Turner
Position in the VCSift Database
- • 2 investors at Montreux Equity Partners are tracked.
- • 1,801 investors hold the Managing Director role in VCSift. Daniel Turner is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Daniel
Search Investors